Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Subviral Agents01:29

Subviral Agents

512
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
512
Viral Mutations00:36

Viral Mutations

39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wound, pressure ulcer, and burn guidelines - 3: Guidelines for the diagnosis and treatment of diabetic ulcers and gangrene, second edition.

The Journal of dermatology·2025
Same author

Evaluation of next-generation sequencing performance for in vitro detection of viruses in biological products.

Biologicals : journal of the International Association of Biological Standardization·2023
Same author

Evaluation of the reproducibility and positive controls of cellular immortality test for the detection of immortalized cellular impurities in human cell-processed therapeutic products.

Regenerative therapy·2022
Same author

A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells.

Scientific reports·2021
Same author

Infectivity assessment of porcine endogenous retrovirus using high-throughput sequencing technologies.

Biologicals : journal of the International Association of Biological Standardization·2021
Same author

Validation of novel identification algorithms for major adverse cardiovascular events in a Japanese claims database.

Journal of clinical hypertension (Greenwich, Conn.)·2020

Related Experiment Video

Updated: Jan 14, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

36.1K

Viral Safety.

Ken Kono1, Satoshi Yasuda1, Yoji Sato2

  • 1Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan.

Advances in Experimental Medicine and Biology
|October 24, 2025
PubMed
Summary

Ensuring viral safety is critical for cell therapy products to prevent patient harm. Advanced technologies, like next-generation sequencing, are essential for robust viral safety assessments in this field.

Keywords:
Endogenous retrovirusICH Q5ANext-generation sequencerNucleic acid sequenceViral safety

More Related Videos

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety
14:03

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety

Published on: July 24, 2011

15.7K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.4K

Related Experiment Videos

Last Updated: Jan 14, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

36.1K
Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety
14:03

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety

Published on: July 24, 2011

15.7K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.4K

Area of Science:

  • Biotechnology
  • Cell Therapy
  • Virology

Background:

  • Viral contamination poses significant risks to patients receiving cell therapy.
  • Ensuring product safety is paramount for the clinical application of cell therapies.
  • Public health preservation necessitates rigorous viral safety evaluations.

Purpose of the Study:

  • To outline a foundational strategy for confirming viral safety in cell therapy products.
  • To present recent advancements in viral safety assessment utilizing next-generation sequencing.
  • To address the need for both common and product-specific viral safety measures.

Main Methods:

  • Reviewing current scientific literature and technological advancements for viral safety.
  • Implementing next-generation sequencing for enhanced viral detection.
  • Developing case-by-case approaches for unique cell therapy products.

Main Results:

  • Established a systematic approach for viral safety confirmation in cell therapies.
  • Demonstrated the utility of next-generation sequencing in identifying viral contaminants.
  • Highlighted the importance of adaptable safety protocols for diverse cell products.

Conclusions:

  • Advanced scientific methods are crucial for ensuring the viral safety of cell therapy products.
  • Next-generation sequencing offers a powerful tool for comprehensive viral safety testing.
  • A combination of standardized and tailored approaches is necessary for effective viral safety management.